المصدر: A Randomized, Double-blind, Vehicle-controlled, Multicenter Phase III Study to Evaluate the Safety, Tolerability, and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using the BF-RhodoLED® XL or BF-RhodoLED® Lamp

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05662202Test

المصدر: A Randomized, Double Blind, Vehicle-controlled, Multicenter Phase II Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris in Adults With Photodynamic Therapy (PDT)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05080764Test

المصدر: A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BF-200 ALA (Ameluz®) in the Expanded Field-directed Treatment of Actinic Keratosis on the Face and Scalp With Photodynamic Therapy (PDT)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05060237Test

المصدر: An Open-label Phase I Study to Evaluate the Pharmacokinetics of 5-aminolevulinic Acid and Protoporphyrin IX in Human Plasma Under Maximal Use Conditions After Topical Application of 3 Tubes of BF-200 ALA 10% Gel for Photodynamic Therapy (PDT) in Subjects Suffering From Actinic Keratosis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04319159Test

المصدر: A Randomized, Double Blind, Vehicle-controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03573401Test

المصدر: A Randomized Placebo-controlled Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02799030Test

المؤلفون: Accovion GmbH

المصدر: Dschka T, Radny P, Domus R, Mensg H, Brung H, Jenne L, Karl L, Sebastn M, Oster-Schmt C, Klovekorn W, Rehold U, Tanner M, Grone D, Dehmann M, Son M, Hubger F, Hofbauer G, Krahn-Senftleben G, Borrosch F, Reh K, Berkg C, Wolf P, Lehmann P, Moers-CarpM, Honsmann H, Wernke-Panten K, Helw C, Foguet M, Schmz B, Lubbert H, Szes RM; AK-CT002 Study Group. Photodynam therapy wh BF-200 ALA for the treatment of act keratos: results of a multentre, randomed, observer-bld phase study comparon wh a regtered methyl-5-amolaevulate cream and placebo. Br J Dermatol. 2012 Jan;166(1):137-46. do 10.1111/j.1365-2133.2011.10613.x. Epub 2011 Dec 21.
Dschka T, Radny P, Domus R, Mensg H, Brung H, Jenne L, Karl L, Sebastn M, Oster-Schmt C, Klovekorn W, Rehold U, Tanner M, Grone D, Dehmann M, Son M, Hubger F, Hofbauer G, Krahn-Senftleben G, Borrosch F, Reh K, Berkg C, Wolf P, Lehmann P, Moers-CarpM, Honsmann H, Wernke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmz B, Lubbert H, Szes RM; AK-CT002 Study Group; AK-CT003 Study Group. Long-term (6 and 12 months) follow-up of two prospecte, randomed, controlled phase trls of photodynam therapy wh BF-200 ALA and methyl amolaevulate for the treatment of act keratos. Br J Dermatol. 2013 Apr;168(4):825-36. do 10.1111/bjd.12158.
A Randomized, Observer Blind, Multinational Phase III Study to Evaluate the Safety and Efficacy of a Nanoemulsion Gel Formulation BF-200 ALA, in Comparison With Metvix® and Placebo, for the Treatment of Actinic Keratosis With PDT

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02799069Test

المصدر: Szeimies RM, Radny P, Sebastian M, Borrosch F, Dirschka T, Krahn-Senftleben G, Reich K, Pabst G, Voss D, Foguet M, Gahlmann R, Lubbert H, Reinhold U. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Br J Dermatol. 2010 Aug;163(2):386-94. doi: 10.1111/j.1365-2133.2010.09873.x. Epub 2010 May 28.
Dirschka T, Radny P, Dominicus R, Mensing H, Bruning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klovekorn W, Reinhold U, Tanner M, Grone D, Deichmann M, Simon M, Hubinger F, Hofbauer G, Krahn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Honigsmann H, Wernicke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmitz B, Lubbert H, Szeimies RM; AK-CT002 Study Group; AK-CT003 Study Group. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol. 2013 Apr;168(4):825-36. doi: 10.1111/bjd.12158.
A Randomized, Double-Blind, Phase III Multi-Center Study Evaluating the Safety and Efficacy of BF-200 ALA Versus Placebo in the Treatment of Actinic Keratosis (AK) When Using PDT

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02799082Test

المصدر: A Randomized, Double-blind, Phase III, Multi-center Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) Versus Placebo in the Field-directed Treatment of Mild to Moderate Actinic Keratosis With Photodynamic Therapy (PDT) When Using the BF-RhodoLED® Lamp

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01966120Test

المؤلفون: Accovion GmbH

المصدر: Morton CA, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, Ulrich M, Keohane S, Ekanayake-Bohlig S, Ibbotson S, Ostendorf R, Berking C, Grone D, Schulze HJ, Ockenfels HM, Jasnoch V, Kurzen H, Sebastian M, Stege H, Staubach P, Gupta G, Hubinger F, Ziabreva I, Schmitz B, Gertzmann A, Lubbert H, Szeimies RM. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. Br J Dermatol. 2018 Aug;179(2):309-319. doi: 10.1111/bjd.16441. Epub 2018 May 16.
A Randomized, Observer Blind, Multinational Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) in Comparison to Metvix® in the Treatment of Non-aggressive Basal Cell Carcinoma (BCC) With Photodynamic Therapy (PDT)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02144077Test

Other URLs: http://www.ncbi.nlm.nih.gov/pubmed/29432644Test